Depressive states are the predominant feature of bipolar disorder and a major source of morbidity and mortality in bipolar patients. Symptoms include affective changes, neurovegetative signs, and significant cognitive deficits. Several lines of evidence suggest that these symptoms are linked to neuropathological abnormalities in structures making up the anterior limbic network (ALN), a brain network hypothesized to modulate emotional homeostasis. These abnormalities are manifest by functional neuroimaging changes in regions involved in emotional control including the ventrolateral prefrontal cortex (VLPFC), anterior cingulate (ACC) and amygdala, as well as by neurochemical changes consistent with elevated neuronal metabolism. Magnetic resonance spectroscopy (MRS) studies of depressed bipolar patients suggest that abnormalities in energy metabolism may underlie increased prefrontal and medial temporal activity observed with functional magnetic resonance imaging (fMRI) and positron emission tomography (PET). Patients with bipolar disorder demonstrate significant changes in prefrontal concentrations of N-acetyl aspartate (NAA), as well as changes in phosphomonoesters (PME) and the presence of lactate, that suggest altered energy metabolism. Evidence of increased glutamate in the prefrontal cortex suggests that this increased neuronal activity is related to increased intraneuronal excitatory signaling within the prefrontal cortex. Together, these data support a model in which bipolar depression is marked by a loss of emotional modulation linked with increased ACC and VLPFC activation, and inhibition of, or interference with other brain regions, including the dorsolateral prefrontal cortex, which mediates cognitive domains impacted by bipolar disorder. These prefrontal changes in neuronal activity appear to be responsive to pharmacologic intervention. With these consideration in mind, the goals of this study are: 1) To use 1H-MRS to identify neurometabolic abnormalities in early-episode depressed bipolar patients, and to determine how abnormalities change in response to specific treatments;and 2) To identify corresponding changes in fMRI brain activation, in order to provide neurofunctional correlates to neurochemical markers of treatment response. To accomplish these aims, we will acquire integrated neurometabolic (MRS) and neurofunctional (fMRI) measurements in earlyepisode depressed bipolar patients and a matched cohort of healthy subjects in order to refine neurophysiological models of bipolar disorder (Center goal 1);to identify MRS and fMRI markers of treatment response in bipolar depression to two mechanistically different medications (Center goal 2);and to identify potential predictors of treatment response for future studies (Center goal 3).

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH077138-03
Application #
7880730
Study Section
Special Emphasis Panel (ZMH1)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
3
Fiscal Year
2009
Total Cost
$206,742
Indirect Cost
Name
University of Cincinnati
Department
Type
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Nery, Fabiano G; Norris, Matthew; Eliassen, James C et al. (2017) White matter volumes in youth offspring of bipolar parents. J Affect Disord 209:246-253
Fleck, David E; Ernest, Nicholas; Adler, Caleb M et al. (2017) Prediction of lithium response in first-episode mania using the LITHium Intelligent Agent (LITHIA): Pilot data and proof-of-concept. Bipolar Disord 19:259-272
McNamara, Robert K; Jandacek, Ronald; Tso, Patrick et al. (2016) Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker. Early Interv Psychiatry 10:203-11
McNamara, Robert K; Moser, Ann B; Jones, Richard I et al. (2016) Familial risk for bipolar disorder is not associated with impaired peroxisomal function: Dissociation from docosahexaenoic acid deficits. Psychiatry Res 246:803-807
Welge, Jeffrey A; Saliba, Lawrence J; Strawn, Jeffrey R et al. (2016) Neurofunctional Differences Among Youth With and at Varying Risk for Developing Mania. J Am Acad Child Adolesc Psychiatry 55:980-989
Strakowski, Stephen M; Fleck, David E; Welge, Jeffrey et al. (2016) fMRI brain activation changes following treatment of a first bipolar manic episode. Bipolar Disord 18:490-501
McNamara, Robert K; Jandacek, Ronald; Tso, Patrick et al. (2015) First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: Dissociation from clinical response to lithium or quetiapine. Psychiatry Res 230:447-53
Jacob, Shawna N; Shear, Paula K; Norris, Matthew et al. (2015) Impact of functional magnetic resonance imaging (fMRI) scanner noise on affective state and attentional performance. J Clin Exp Neuropsychol 37:563-70
Strawn, Jeffrey R; Adler, Caleb M; McNamara, Robert K et al. (2014) Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study. Bipolar Disord 16:523-30
Cerullo, Michael A; Eliassen, James C; Smith, Christopher T et al. (2014) Bipolar I disorder and major depressive disorder show similar brain activation during depression. Bipolar Disord 16:703-12

Showing the most recent 10 out of 28 publications